These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38217867)

  • 1. Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Tetzloff KA; Martin PR; Duffy JR; Utianski RL; Clark HM; Botha H; Machulda MM; Thu Pham NT; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2024 May; 147(5):1696-1709. PubMed ID: 38217867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans.
    Gatto RG; Pham NTT; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Lowe VJ; Schwarz CG; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2024 Jun; 45(8):e26704. PubMed ID: 38825988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging-based multi-fiber tracking reconstructions can regionally differentiate phonetic versus prosodic subtypes of progressive apraxia of speech.
    Gatto RG; Martin PR; Utianski RL; Duffy JR; Clark HM; Botha H; Machulda MM; Josephs KA; Whitwell JL
    Cortex; 2024 Feb; 171():272-286. PubMed ID: 38061209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prosodic and phonetic subtypes of primary progressive apraxia of speech.
    Utianski RL; Duffy JR; Clark HM; Strand EA; Botha H; Schwarz CG; Machulda MM; Senjem ML; Spychalla AJ; Jack CR; Petersen RC; Lowe VJ; Whitwell JL; Josephs KA
    Brain Lang; 2018 Sep; 184():54-65. PubMed ID: 29980072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial patterns of elevated magnetic susceptibility in progressive apraxia of speech.
    Satoh R; Arani A; Senjem ML; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Jack CR; Whitwell JL; Josephs KA
    Neuroimage Clin; 2023; 38():103394. PubMed ID: 37003130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.
    Utianski RL; Whitwell JL; Schwarz CG; Senjem ML; Tosakulwong N; Duffy JR; Clark HM; Machulda MM; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Cortex; 2018 Feb; 99():358-374. PubMed ID: 29353121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Speech Errors Across Primary Progressive Apraxia of Speech Subtypes.
    Tetzloff KA; Duffy JR; Clark HM; Josephs KA; Whitwell JL; Utianski RL
    J Speech Lang Hear Res; 2024 Mar; 67(3):811-820. PubMed ID: 38376491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Senjem ML; Master AV; Lowe VJ; Jack CR; Whitwell JL
    Brain; 2012 May; 135(Pt 5):1522-36. PubMed ID: 22382356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.
    Josephs KA; Duffy JR; Clark HM; Utianski RL; Strand EA; Machulda MM; Botha H; Martin PR; Pham NTT; Stierwalt J; Ali F; Buciuc M; Baker M; Fernandez De Castro CH; Spychalla AJ; Schwarz CG; Reid RI; Senjem ML; Jack CR; Lowe VJ; Bigio EH; Reichard RR; Polley EJ; Ertekin-Taner N; Rademakers R; DeTure MA; Ross OA; Dickson DW; Whitwell JL
    Nat Commun; 2021 Jun; 12(1):3452. PubMed ID: 34103532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal flortaucipir ([
    Utianski RL; Martin PR; Botha H; Schwarz CG; Duffy JR; Petersen RC; Knopman DS; Clark HM; Butts AM; Machulda MM; Jack CR; Lowe VJ; Whitwell JL; Josephs KA
    Cortex; 2020 Mar; 124():33-43. PubMed ID: 31830664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal characterization of patients with progressive apraxia of speech without clearly predominant phonetic or prosodic speech features.
    Utianski RL; Meade G; Duffy JR; Clark HM; Botha H; Machulda MM; Dickson DW; Whitwell JL; Josephs KA
    Brain Lang; 2023 Oct; 245():105314. PubMed ID: 37607419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech.
    Sintini I; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Senjem ML; Strand EA; Schwarz CG; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Neurobiol Aging; 2022 Dec; 120():105-116. PubMed ID: 36166918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
    Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
    Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic Analysis and Neuroimaging Correlates of Diadochokinetic Rates in Mild-Moderate Primary Progressive Apraxia of Speech.
    Josephs KA; Duffy JR; Martin PR; Stephens YC; Singh NA; Clark HM; Botha H; Lowe VJ; Whitwell JL; Utianski RL
    Brain Lang; 2023 May; 240():. PubMed ID: 37584042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.